These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20648469)

  • 1. [Hallucinations caused by the introduction of methylphenidate at low doses].
    Aguilera-Albesa S; Yoldi-Petri ME; Molins-Castiella T; Durá-Travé T
    Rev Neurol; 2010 Aug; 51(4):254-5. PubMed ID: 20648469
    [No Abstract]   [Full Text] [Related]  

  • 2. [Visual hallucinations caused by methylphenidate].
    Tomás Vila M; Izquierdo Quevedo FJ; Cerdán Vera MT; Fernández A; Artés Figueres M; Revert Gomas M
    An Pediatr (Barc); 2010 Mar; 72(3):229-30. PubMed ID: 20097145
    [No Abstract]   [Full Text] [Related]  

  • 3. Methylphenidate-induced visual hallucinations.
    Porfirio MC; Giana G; Giovinazzo S; Curatolo P
    Neuropediatrics; 2011 Feb; 42(1):30-1. PubMed ID: 21500140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excessive masturbation and hypersexual behavior associated with methylphenidate.
    Bilgiç A; Gürkan K; Türkoğlu S
    J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):789-90. PubMed ID: 17581441
    [No Abstract]   [Full Text] [Related]  

  • 5. Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination.
    Coskun M; Zoroglu S
    J Clin Psychopharmacol; 2008 Dec; 28(6):723-5. PubMed ID: 19011457
    [No Abstract]   [Full Text] [Related]  

  • 6. Methylphenidate induction of complex visual hallucinations.
    Halevy A; Shuper A
    J Child Neurol; 2009 Aug; 24(8):1005-7. PubMed ID: 19502578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The change of the cortisol levels in children with ADHD treated by methylphenidate or atomoxetine.
    Chen YH; Lin XX; Chen H; Liu YY; Lin GX; Wei LX; Hong YL
    J Psychiatr Res; 2012 Mar; 46(3):415-6. PubMed ID: 22169529
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug dependence and methylphenidate].
    Sora I; Ikari M; Ikeda K
    Seishin Shinkeigaku Zasshi; 2008; 110(10):941-5. PubMed ID: 19278070
    [No Abstract]   [Full Text] [Related]  

  • 9. Abuse and toxicity of methylphenidate.
    Klein-Schwartz W
    Curr Opin Pediatr; 2002 Apr; 14(2):219-23. PubMed ID: 11981294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile Huntington disease exacerbated by methylphenidate: case report.
    Waugh JL; Miller VS; Chudnow RS; Dowling MM
    J Child Neurol; 2008 Jul; 23(7):807-9. PubMed ID: 18658080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.
    Leonard BE; McCartan D; White J; King DJ
    Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851
    [No Abstract]   [Full Text] [Related]  

  • 12. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Killeen MR
    J Child Fam Nurs; 2000; 3(1):46-8. PubMed ID: 11022478
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
    Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
    Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Raynaud phenomenon as adverse effect of ADHD treatment].
    Lakartidningen; 2008 Dec 10-16; 105(50):3662-3. PubMed ID: 19177933
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourette's syndrome.
    Sverd J; Gadow KD; Paolicelli LM
    J Am Acad Child Adolesc Psychiatry; 1989 Jul; 28(4):574-9; discussion 580-2. PubMed ID: 2768152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pica in a child with attention deficit hyperactivity disorder and successful treatment with methylphenidate.
    Hergüner S; Hergüner AS
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1155-6. PubMed ID: 20547198
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanism for the efficacy of methylphenidate on attention deficit/hyperactivity disorder and related clinical evidence].
    Okada T
    Seishin Shinkeigaku Zasshi; 2008; 110(10):932-40. PubMed ID: 19278069
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychosis induced by the interaction between disulfiram and methylphenidate may be dose dependent.
    Grau-López L; Roncero C; Navarro MC; Casas M
    Subst Abus; 2012; 33(2):186-8. PubMed ID: 22489591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of methylphenidate for attention deficit hyperactivity disorder. Mental Health Committee, Canadian Paediatric Society.
    CMAJ; 1990 Apr; 142(8):817-8. PubMed ID: 2322913
    [No Abstract]   [Full Text] [Related]  

  • 20. Methylphenidate-associated enuresis in attention deficit hyperactivity disorder.
    Ghanizadeh A
    J Pediatr Urol; 2008 Aug; 4(4):306-7. PubMed ID: 18644535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.